2023 tables: Institutions - biological sciences - corporate

The 2023 tables are based on Nature Index data from 1 January 2022 to 31 December 2022.

Table criteria

Request a badge Export CSV
# Institution Share 2021 Share 2022 Count 2022 Change in Adjusted Share* 2021–2022
1 BGI, China 8.83 12.78 49 57.3%
2 Formosa Plastics Group, Taiwan 4.25 6.12 22 56.4%
3 Takeda Pharmaceutical Company Limited, Japan 6.12 2.09 9 -62.8%
4 Nippon Telegraph and Telephone Corporation (NTT), Japan 0.04 1.83 6 5463.1%
5 Innovent Biologics, Inc., China 1.13 1.76 5 70.4%
6 Institute of Environmental Science and Research (ESR), New Zealand 0.71 1.57 6 139.2%
7 ToolGen, Inc., South Korea – 1.54 3 N/A
8 China State Shipbuilding Corporation Limited (CSSC), China 1.84 1.53 45 -9.8%
9 China National Chemical Corporation (ChemChina), China 0.77 1.44 5 102.9%
10 Daiichi Sankyo Co., Ltd., Japan 0.17 1.28 7 734.4%
11 China National Pharmaceutical Group (Sinopharm), China 0.92 1.23 2 44.9%
12 Shionogi & Co., Ltd., Japan 0.33 1.22 6 297.1%
13 The New Zealand Institute for Plant and Food Research Ltd., New Zealand 0.28 1.10 15 329.9%
14 Shanghai United Imaging Healthcare Co., Ltd. (UIH), China 0.04 1.07 5 3002.5%
15 The Australian Wine Research Institute (AWRI), Australia – 1.06 2 N/A
16 Nissan Chemical Corporation, Japan – 1.00 1 N/A
16 Yakult Central Institute for Microbiological Research, Japan 0.73 1.00 1 49.5%
17 FiberHome Technologies Group, China 1.38 0.98 13 -22.5%
18 Eisai Co., Ltd., Japan 3.03 0.93 3 -66.8%
19 Samsung Group, South Korea 0.67 0.80 18 30.7%
20 Sinovac Biotech Co., Ltd., China – 0.80 4 N/A
21 Kao Corporation, Japan – 0.77 2 N/A
22 United BioPharma, Inc., Taiwan – 0.76 2 N/A
23 Etern Biopharma Co. Ltd., China – 0.73 1 N/A
24 Epsilon Molecular Engineering Inc., Japan – 0.67 1 N/A
25 Zhejiang Tianke High-tech Development Co., Ltd., China – 0.66 2 N/A
26 Tencent, China 0.65 0.65 3 9.0%
27 Nippi. Inc., Japan 0.69 0.65 2 2.5%
28 GENUV, Inc., South Korea – 0.64 1 N/A
29 Gero Pte. Ltd., Singapore 0.56 0.63 1 22.4%
30 Ono Pharmaceutical Co., Ltd., Japan – 0.60 6 N/A
31 TIPR Pharmaceutical Co., Ltd., China – 0.59 8 N/A
32 BeiGene Ltd., China – 0.59 2 N/A
33 Precision Scientific (Beijing) Co., Ltd., China 0.57 0.57 1 9.7%
34 Annoroad Gene Technology Co., Ltd., China 0.05 0.53 4 1054.5%
35 AmorePacific Corporation, South Korea – 0.50 1 N/A
35 Beijing Jingtai Technology Co., Ltd., China – 0.50 1 N/A
35 Geneplus-Beijing Institute, China 0.85 0.50 1 -35.7%
36 Konica Minolta, Inc., Japan 0.14 0.48 5 280.6%
37 Alibaba Group Holding Limited, China 0.22 0.47 13 131.6%
38 GI Innovation Co., Ltd., South Korea – 0.47 1 N/A
39 Sinochem Group, China – 0.46 1 N/A
40 Novogene Co., Ltd., China 0.50 0.46 5 -0.4%
41 Centre for Novostics Limited, China 0.28 0.44 2 70.5%
42 Shanghai Bioray Laboratory Inc. (BRL), China – 0.42 3 N/A
43 JEOL Ltd., Japan 0.27 0.42 6 65.1%
44 Alimetry Ltd., New Zealand – 0.40 1 N/A
45 Sony Corporation, Japan 0.00 0.40 3 106483.0%
45 AbacusBio Ltd., New Zealand – 0.40 1 N/A
46 Kcat Enzymatic Private Limited, India – 0.39 1 N/A
47 GenKOre Inc., South Korea 0.27 0.39 1 57.6%
48 Purotech Bio Inc., Japan – 0.38 1 N/A
49 Wuxi Biortus Biosciences Co., Ltd., China 0.05 0.38 3 684.2%
50 Autotac Bio, South Korea 0.08 0.38 1 394.4%

Footnote

Each year, the Nature Index publishes tables based on counts of high-quality research outputs in the previous calendar year. Users please note:

  1. The data behind the tables are based on a relatively small proportion of total research papers, they cover the natural sciences only and outputs are non-normalized (that is, they don’t reflect the size of the country or institution, or its overall research output).
  2. The Nature Index is one indicator of institutional research performance. The metrics of Count and Share used to order Nature Index listings are based on an institution’s or country’s publication output in 82 natural-science journals through 2022, in 2023 64 health-science journals were added to the Index. The 146 journals in the Nature Index were selected on reputation by an independent panel of leading scientists in their fields.
  3. Nature Index recognizes that many other factors must be taken into account when considering research quality and institutional performance; Nature Index metrics alone should not be used to assess institutions or individuals.
  4. Nature Index data and methods are transparent and available under a creative commons licence at nature.com/nature-index/.
  5. Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

The Nature Index database undergoes regular updating, corrections, adjustment of institutional hierarchies, and removal of retracted papers and thus the live website can differ from the frozen annual tables.

*The change in adjusted Share accounts for the small annual variation in the total number of articles in Nature Index journals. Share values have been adjusted to 2022 levels to calculate the percentage change. For more information on the adjustment, please see the Adjusted metric explainer.


Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.